Position in ALKS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$777,803
+$390,728 QoQ
Shares Held
14,845
+7.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#223
of 421 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $47,589,456 across 19 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
268,913 | $19,324,087 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
58,156 | $9,801,612 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
12,132 | $6,573,480 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
126,338 | $4,280,331 | |
| 5 | VTRS |
Viatris Inc
|
102,912 | $1,634,242 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
44,054 | $1,084,168 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
7,039 | $780,906 | |
| 8 | ALKS |
Alkermes plc.
This page
|
14,845 | $777,803 |
All Filings in ALKS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $777,803 | 14,845 | Principal | Sole | 2026-07-29 | |
| 2025-12-31 | $387,075 | 13,834 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $221,190 | 7,373 | Shares | Sole | 2025-12-02 | |
| No filing history on record for this holder in this stock. | ||||||